New asthma shot aims to tame severe attacks
NCT ID NCT05472324
Summary
This study tested whether a new injectable medication called TQC2731 could help adults with severe asthma that remains poorly controlled despite standard treatments. Over 200 participants received either one of three doses of TQC2731 or a placebo injection every four weeks for a year. Researchers measured if the treatment reduced the yearly rate of serious asthma flare-ups and improved lung function and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GUANGZHOU FIRST PEOPLE's HOSPITAL
Guangzhou, Guangdong, 510180, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450000, China
Conditions
Explore the condition pages connected to this study.